Results 131 to 140 of about 278 (206)
Legal aspects of privacy-enhancing technologies in genome-wide association studies and their impact on performance and feasibility. [PDF]
Brauneck A +7 more
europepmc +1 more source
Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing. [PDF]
Evans BJ.
europepmc +1 more source
Contradicting rulings of the US patent office on double patenting jeopardize the generic and biosimilar drugs. [PDF]
Niazi SK.
europepmc +1 more source

